ABBV(AbbVie Inc.) 的财务报表:医疗保健,综合制药。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 科目 | FY 截至 2021-12-31 | FY 截至 2022-12-31 | FY 截至 2023-12-31 | FY 截至 2024-12-31 | FY 截至 2025-12-31 |
|---|---|---|---|---|---|
| 营业收入 | $56.20B | $58.05B | $54.32B | $56.33B | $61.16B |
| 毛利润 | $38.75B | $40.64B | $33.90B | $39.43B | $42.96B |
| 营业利润 | $17.92B | $18.12B | $12.76B | $9.14B | $15.07B |
| 净利润 | $11.54B | $11.84B | $4.86B | $4.28B | $4.23B |
| 经营现金流 | $22.78B | $24.94B | $22.84B | $18.81B | $19.03B |
| 自由现金流 | $21.99B | $24.25B | $22.06B | $17.83B | $17.82B |
| 摊薄每股收益 | $6.45 | $6.63 | $2.72 | $2.39 | $2.36 |